SMFM updated, “Provider Considerations for Engaging in COVID-19 Vaccine Counseling With Pregnant and Lactating Patients,” to include the latest information on boosters.

SMFM and ACOG recommend that pregnant people receive a COVID-19 booster shot at least 6 months after their primary series for mRNA-based vaccines (ie, Pfizer or Moderna) and at least…

Read More from SMFM updated, “Provider Considerations for Engaging in COVID-19 Vaccine Counseling With Pregnant and Lactating Patients,” to include the latest information on boosters.

SMFM has updated Provider Considerations for Engaging in COVID-19 Vaccine Counseling With Pregnant and Lactating Patients

SMFM recommends that pregnant and lactating people be vaccinated against COVID- 19. The Centers for Disease Control and Prevention  (CDC) state that “COVID-19 vaccination is recommended for all people aged…

Read More from SMFM has updated Provider Considerations for Engaging in COVID-19 Vaccine Counseling With Pregnant and Lactating Patients

Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism

Amniotic fluid embolism is a rare syndrome characterized by sudden cardiorespiratory collapse during labor or soon after delivery. Because of its rarity, many obstetrical providers have no experience in managing…

Read More from Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism

Society for Maternal-Fetal Medicine Consult Series #54: Assessing the risk of maternal morbidity and mortality

The rates of maternal morbidity and mortality in the United States demand a comprehensive approach to assessing pregnancy-related risks. Numerous medical and nonmedical factors contribute to maternal morbidity and mortality….

Read More from Society for Maternal-Fetal Medicine Consult Series #54: Assessing the risk of maternal morbidity and mortality

Leaders in Women’s Health Encourage Health Workers to Receive the COVID-19 Vaccine – Vaccination is the Key to Preventing New Infections

ACNM, ACOG, ASRM, AWHONN, NPWH, SMFM, and SOGH have released a joint statement to encourage health workers to receive the COVID-19 vaccine. During the COVID-19 pandemic, public health measures such…

Read More from Leaders in Women’s Health Encourage Health Workers to Receive the COVID-19 Vaccine – Vaccination is the Key to Preventing New Infections

SMFM: Provider Considerations for Engaging in COVID-19 Vaccine Counseling With Pregnant and Lactating Patients

SMFM strongly recommends that pregnant and lactating people have access to the COVID-19 vaccines and that they engage in a discussion about potential benefits and unknown risks with their healthcare…

Read More from SMFM: Provider Considerations for Engaging in COVID-19 Vaccine Counseling With Pregnant and Lactating Patients

Society for Maternal Fetal Medicine: Coronavirus (COVID-19) and Pregnancy (11.23.20 update)

What Maternal-Fetal Medicine Subspecialists Need to Know – 11.23.20 (this is an update of the draft originally posted on 10.26.2020) COVID19-What_MFMs_need_to_know_revision_11-23-20_final Please to visit our COVID-19 Resources page for more information…

Read More from Society for Maternal Fetal Medicine: Coronavirus (COVID-19) and Pregnancy (11.23.20 update)

Register now for SMFM’s Oct 23 and 24 training: A Virtual Course for OBGYNs, MFMs, Midwives, Nurses, Nurse Practitioners, Women’s Health Nurse Practitioners, and Hospital Safety and Quality Staff

In August 2019, The Joint Commission (TJC) introduced new standards for perinatal safety. These standards are similar to the bundles on obstetric hemorrhage and severe hypertension introduced by the Alliance…

Read More from Register now for SMFM’s Oct 23 and 24 training: A Virtual Course for OBGYNs, MFMs, Midwives, Nurses, Nurse Practitioners, Women’s Health Nurse Practitioners, and Hospital Safety and Quality Staff

Society for Maternal-Fetal Medicine is offering resources to non-members through June 30 and other upcoming webinars

RELEASED LAST WEEK Under the leadership of the Health Policy and Advocacy Committee, SMFM wrote a letter to the U.S. House of Representatives and Senate leadership last week, detailing SMFM’s…

Read More from Society for Maternal-Fetal Medicine is offering resources to non-members through June 30 and other upcoming webinars

AJOG/SMFM: COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals

Abstract: The novel corona virus 2019, or COVID-19, infection has rapidly spread through the New York metropolitan area since the first reported case in the state on March 1, 2020….

Read More from AJOG/SMFM: COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals

Now Available – Society for Maternal Fetal Medicine’s Webinar: COVID-19 in Pregnancy: Preparing your Obstetrical Units on 3/19

March 19, 2020: SMFM hosted a live webinar with Drs. Judette Louis, Christina Han, and Kimberly Ma, “COVID-19 in Pregnancy: Preparing your Obstetrical Units.” The recorded version of this webinar is available here: Society for Maternal…

Read More from Now Available – Society for Maternal Fetal Medicine’s Webinar: COVID-19 in Pregnancy: Preparing your Obstetrical Units on 3/19

ACOG Practice Advisory/SMFM Clinical Statement: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women

Washington, DC – The American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) released the following statement in response to the results of “A Randomized Trial of…

Read More from ACOG Practice Advisory/SMFM Clinical Statement: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women

SMFM Statement: The Choice of Progestogen for the Prevention of Preterm Birth in Women with Singleton Pregnancy and Prior Preterm Birth

The Society for Maternal-Fetal Medicine (SMFM) has released a statement addressing the use of 17-alpha hydroxyprogesterone caproate (17-OHPC) therapy to prevent preterm birth (PTB) out of concern that women who…

Read More from SMFM Statement: The Choice of Progestogen for the Prevention of Preterm Birth in Women with Singleton Pregnancy and Prior Preterm Birth